We help governments, hospital groups, and healthcare providers deploy internationally benchmarked ADHD and autism assessment services. From clinician training to national framework design.
Start a ConversationFor institutional partners and healthcare providers
Neurodivergent conditions, including ADHD and autism, affect an estimated 15 to 20% of the global population. Across the Middle East, recognition of these conditions as a healthcare and public policy priority is accelerating.
Yet diagnostic capacity in the region remains critically inadequate. Waiting times for assessment are long where services exist, diagnostic quality is inconsistent, and the clinical workforce trained to deliver internationally benchmarked assessments is small.
This is not a niche market opportunity. It is a structural gap in regional healthcare infrastructure.
National development agendas across the GCC have created the conditions and the funding for world-class neurodiversity infrastructure.
Explicit commitments to mental health and disability service development, with significant sovereign wealth fund capital directed into healthcare infrastructure build-out.
The National Mental Health Strategy and Abu Dhabi's Healthcare Masterplan 2030 both identify neurodevelopmental services as a priority gap requiring investment.
Multinational corporations and international schools across the GCC are under increasing pressure to provide ND assessment pathways for their workforces and students.
Whether you need to train a clinical team or design a national framework, we meet you at your starting point and build from there.
Intensive, internationally accredited training in ADHD and autism assessment for your existing clinical team. Covers ADOS-2, ADI-R, DIVA-5, clinical interview methodology, report writing, and peer review protocols. Your clinicians assess with confidence from day one.
Operational review, quality framework implementation, patient journey optimisation, and digital marketing strategy. Built for providers already delivering ND assessments who need to scale volume and add clinicians without the quality degradation that typically follows.
The complete package: clinical methodology, clinician training, operational handbook, technology platform, marketing and patient acquisition, and ongoing quality assurance. Everything you need to launch a world-class ND assessment service from within your existing practice.
Landscape assessment, national diagnostic standards, clinical workforce development strategy, technology and infrastructure roadmaps, and regulatory alignment. For partners operating at the scale of national policy and population health.
Our methodology has been developed and refined through thousands of ADHD and autism assessments delivered across the UK and Ireland. We are the only organisation globally that offers clinician training in ADOS-2, ADI-R, and DIVA-5 while simultaneously operating a full diagnostic service.
What this means for you: the methodology being brought to the Middle East is not theoretical. It has been tested, iterated, and refined through years of real clinical delivery at scale. Every protocol, every quality standard, every training module comes from a live operation that produces measurable clinical outcomes every single day.
Our clinical leadership team, led by Sarah Phelan, a practising neurodiversity expert who is herself neurodivergent, brings deep expertise in building and scaling diagnostic services to international standards.
Every single assessment is peer-reviewed before diagnosis is finalised. Not for complex cases only. Universally. This is the defining quality signal in a market where diagnostic rigour matters.
Assessing clinician, peer reviewer, and senior expert discuss findings with the patient together. Almost no other provider anywhere in the world does this. It builds diagnostic confidence and justifies premium positioning.
A proven clinical operation across the UK and Ireland with years of iterative refinement. Not a model built for export on paper. A system forged through real-world clinical delivery at volume.
All clinical standards benchmarked against NICE guidelines (NG87, NG142), DSM-5, and ICD-11. Internationally recognised, locally adapted for each GCC jurisdiction.
Our founding team and many of our clinicians are themselves neurodivergent. This creates a fundamentally different culture and clinical sensitivity that traditional medical practices cannot replicate.
From initial enquiry through assessment, diagnosis, group feedback, aftercare, counselling, and ongoing support. Diagnosis is the beginning of the journey, not the end.
We work with organisations that have the scale, ambition, and commitment to build neurodiversity assessment infrastructure that meets international standards.
National framework design, policy alignment, workforce strategy
New service line deployment, clinician training, quality assurance
Operational scaling, clinical accreditation, patient acquisition
KPI frameworks, governance reporting, clinical infrastructure due diligence
Whether you are exploring the opportunity or ready to move, we would welcome a conversation about what world-class ND assessment could look like in your market.
You can also reach us directly at:
hello@globalndsolutions.comComplete our short enquiry form and we will be in touch. We ask a few questions upfront so we are well prepared when we speak with you.
Complete Enquiry FormWe typically respond within 2 business days.